Provided by Tiger Trade Technology Pte. Ltd.

Invesco Nasdaq Biotechnology ETF

34.57
+0.32000.93%
Volume:8K
Turnover:282.30K
Market Cap:96.10M
PE:- -
High:34.62
Open:34.39
Low:34.37
Close:34.25
52wk High:36.84
52wk Low:23.42
Shares:2.78M
Float Shares:2.78M
Volume Ratio:0.98
T/O Rate:0.29%
Dividend:0.26
Dividend Rate:0.74%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Palo Alto, Eaton, Amgen, SpaceX, LMT Trending With Analysts

TIPRANKS
·
Sep 12

Amgen Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 12

Moderna Inc. Stock Rallies 5.4%, Outperforms Peers

Dow Jones
·
Sep 12

Regeneron and Sanofi Complete Key Dupilumab Itch Study, Expanding Dermatology Upside

TIPRANKS
·
Sep 12

Political and General News Events from September 11

Reuters
·
Sep 11

Innovative Drugs Face a Key Data Catalyst Window! Can't Tell OS, PFS, and ORR Apart? Here's a Quick Reference Guide! Save It for Later

Deep News
·
Sep 11

Market-Wide Pullback on Heavy Volume: Nonferrous Metals Hit Hard, Innovative Drugs Keep Sliding, Optical Modules Stand Out as AI ETF Stages a V-Shape Rebound

Deep News
·
Sep 11

Innovative Drug Stocks Remain Under Pressure Ahead of Key Medical Conference; Huabao HK Connect Innovative Drug ETF Breaks Below All Moving Averages

Deep News
·
Sep 11

Shenyang Xingqi Gains Nod for Eye Drop Candidate Clinical Study

Stock News
·
Sep 11

Anglikang's In-Licensing Deal Collapses: Core Business Pressures Compound Innovation Pipeline Uncertainty

Deep News
·
Sep 11

Apichope's gout drug AR882 meets primary endpoint in Phase III trial with projected peak sales of 1.95 billion yuan in Greater China

Deep News
·
Sep 11

Vertex Minerals Confirms Reward Gold Mine Resource After ASX‑Driven Update

TIPRANKS
·
Sep 11

HK Stock Market Update | Innovative Drug Stocks Face Continued Pullback Amid Shifting Overseas Rate Expectations and Post-2026 Negotiation Uncertainty

Stock News
·
Sep 11

Regulatory Intervention Halts Trading of Eye-Care Drug Developer Following Suspected IPO Irregularities

Deep News
·
Sep 11

Vertex Pharma EVP Jasper Van Grunsven Files Initial Beneficial Ownership Statement

Reuters
·
Sep 11

Champions Oncology Q1 Revenue Rises on Research Services Business

Reuters
·
Sep 11

Amgen’s New Repatha Plaque Trial: What Investors Should Watch

TIPRANKS
·
Sep 11

Regeneron Pharmaceuticals More Likely to Retain Eylea HD Patent, RBC Says

MT Newswires Live
·
Sep 10

Dow's 300-Point Drop Led by Losses in Shares of Nvidia Corp., Amgen

Dow Jones
·
Sep 10

Market Wrap September 10: Innovation Drug Shares Dip Amid Clinical Setback, Bank Stocks Post Modest Gains

Stock News
·
Sep 10